Key facts
| Price (PPV) | 1,028 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | vinorelbine |
| Class | Antineoplastic agents |
| ATC code | L01CA04 |
| Manufacturer | MAPHAR |
| Presentation | Boîte de 1 |
| Nature | Médicament |
| Hospital price | 750 MAD |
| Data collected on | 9/8/2026 |
Indications
La NAVELBINE orale est indiquée en monochimiothérapie et en polychimiothérapie dans le traitement du : - cancer du poumon non à petites cellules, - cancer du sein métastatique.
Find an open pharmacy
On-call pharmacies near you
About Navelbine 30 mg
Navelbine 30 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Navelbine 30 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Navelbine 30 mg
Answers to common questions from Moroccan patients about this drug.